Micronutrients Might Help Women With Antenatal Depression, And Their Babies
June 21, 2024
Scientists Develop First Test That Can Predict Dementia Nine Years Before Diagnosis
June 21, 2024

Oprah Winfrey Sparks Fears As She’s Hospitalized With ‘Very Serious’ Illness After Weight Loss Drug

Share this post:


Oprah Winfrey revealed her stunning transformation late last year, and she later confessed she had used a weight loss drug to help her shift the pounds, but she didn’t specify which one.
[Source: mirror.co.uk]

[Image source: Wikimedia]


Aided by widespread promotion through the mainstream/legacy media, weight loss drugs such as Ozempic and Mounjaro have become increasingly popular over the past couple of years. Demand for these drugs is often fueled by stories about celebrities and so-called ‘social media influencers’ using them to achieve a ‘stunning transformation’ of their body shape.

Weight loss drugs are far from being without risk, however. Ozempic can cause inflammation of the pancreas, kidney problems, gallbladder problems, and serious allergic reactions, while Mounjaro can result in nausea, vomiting, severe allergic reactions, and a risk of thyroid cancer. When the drugs are discontinued, patients often regain most or all of the weight they had lost.

Much of the global obesity problem can be attributed to the consumption of ultra-processed foods, which has increased markedly during recent decades. In countries such as the United States, Canada and the UK, such foods now account for over 60 percent of the average adult’s diet.

The obesity problem is not solely confined to the Western world, however. Over the past two decades, the fast-food industry and obesity rates have grown rapidly in China. Research shows that over one-third of Chinese adults are now overweight or obese. In major Chinese cities, such as Beijing or Shanghai, the problem is even worse. In such areas, more than half of the adult population is now overweight.

To learn about the dangers of ultra-processed foods, see this article on our website.

Share this post: